NFKB1 and cancer: Albeit currently proposed to be associated with chronic STING activation (Decout et al., 2021), little is known of the mechanisms regulating the engagement of STING-dependent pro-inflammatory NF-κB factors in the context of acute genotoxic treatment of cancer cells.